Trials / Terminated
TerminatedNCT02212210
Maternal Epidural Steroids and Hyperthemia
Maternal Epidural Steroids to Prevent Neonatal Exposure to Hyperthermia and Inflammation
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.
Detailed description
The association between epidural analgesia and increased maternal intrapartum temperature has been well documented in multiple randomized controlled trials. The exact mechanism for this elevation in temperature is unknown; however the most likely cause appears to be non-infectious inflammatory stimulation. Fetal exposure to maternal fever in utero has been linked with increased antibiotic treatment, increased neonatal sepsis evaluation, and longer length of stay for neonates. In addition there is evidence to suggest intrapartum fevers may lower the threshold for fetal hypoxic brain injury and increase the risk of cerebral palsy. The risk of neonatal encephalopathy in infants born to febrile mothers is 1% compared to 0.1% to afebrile mothers. Safe interventions are needed to prevent adverse fetal outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone | |
| DRUG | Normal saline |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-04-01
- Completion
- 2015-10-01
- First posted
- 2014-08-08
- Last updated
- 2017-08-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02212210. Inclusion in this directory is not an endorsement.